List view / Grid view
26 June 2019 | By Merck
For pharmaceutical companies, patient safety has always been the priority. That’s why pyrogen detection has become a mandatory Quality Control test for release of any parenteral drug.
26 June 2019 | By European Pharmaceutical Review
In this edition, two companies showcase their services and highlight how they stand out from the crowd. The exponential speed of the information technology evolution is rapidly being accepted and integrated into our everyday life, yet it remains a challenge in the laboratory.
26 June 2019 | By Particle Measuring Systems
With a continual focus on data integrity and helping our customers meet regulations while generating actionable insights, Particle Measuring Systems provides a complete range of products and services.
26 June 2019 | By ELGA LabWater
To ensure that USP/EP standards are met, TOC of highly purified water can be determined by internal purification-process monitoring.
25 June 2019 | By European Pharmaceutical Review
Analytical techniques for QA/QC purposes are integral to the safe production of therapeutics. This in-depth focus looks at Raman spectroscopy for amorphous phase analysis and discusses the viable but non-culturable (VBNC) state of bacteria in environmental monitoring.
25 June 2019 | By Contec
Biocidal products manufactured in or imported into the EU or European Economic Area must be authorised for compliance with the requirements of the EU Biocidal Products Regulation (BPR) and any relevant national legislation before being placed on the market.
25 June 2019 | By European Pharmaceutical Review
The process of manufacturing a biotherapeutic drug entails numerous quality control measures to ensure safety and efficacy. The articles in this in-depth focus discuss higher order structure analysis and host cell protein contamination issues.
25 June 2019 | By European Pharmaceutical Review
The latest research and developments from Pharma and Biopharma industry experts.
25 June 2019 | By Merck
Metallic contamination in drug products, referred to as elemental impurities, may arise from several sources.
25 June 2019 | By Victoria Rees (European Pharmaceutical Review)
The FDA has told its staff that it will be assigning drug compounding to the Office of Compliance.
24 June 2019 | By Merck
In this paper the suitability of reagent water for LC-MS biomedical analyses will be evaluated and the role of water quality in achieving sensitive and reliable LC-MS analyses will be discussed.
24 June 2019 | By OSIsoft
Having a holistic data infrastructure in place can not only save time by providing key real-time information and money through readily-accessible, enterprise-wide intelligence, it can also ensure stress-free operations.
21 June 2019 | By Bio-Rad
The elimination of product and process related impurities is essential to the safety and efficacy of biopharmaceuticals.
21 June 2019 | By Victoria Rees (European Pharmaceutical Review)
The company has announced a recall of products which were intended to be sterile after a lack of sterility assurance.
21 June 2019 | By Victoria Rees (European Pharmaceutical Review)
A multi-company system to improve traceability of pharmaceutical products is newly supported by the FDA.
Follow: